Literature DB >> 10439424

Vascular compression of cranial nerves: II: pathophysiology.

A R Møller1.   

Abstract

The pathophysiology of trigeminal neuralgia, hemifacial spasm and other disorders that can be cured by microvascular decompression of cranial nerves, is reviewed and different hypotheses about its pathophysiology are discussed. It is found that the pathophysiology of these disorders is complex and other factors than vascular compression are necessary to cause symptoms. While the efficacy of the microvascular decompression (MVD) operation is indisputable, it is questionable if the symptoms and signs of these disorders are caused by abnormal neural activity in the respective cranial nerves that result from the compression from a blood vessel. Instead, studies point to hyperactivity and hyperexcitability of the respective nuclei as a cause of the symptoms and signs of these disorders. Results of several studies indicate that irritation of the cranial nerve in question from close contact with a blood vessel may promote such development, and it seems necessary that other factors in addition to the vascular contact must be present in order that such a condition develops.

Entities:  

Mesh:

Year:  1999        PMID: 10439424

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  18 in total

1.  Hemifacial spasm: a neurosurgical perspective.

Authors:  Doo-Sik Kong; Kwan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

2.  Microvascular decompression for hemifacial spasm: focus on late reoperation.

Authors:  Xuhui Wang; Parthasarathy D Thirumala; Aalap Shah; Paul Gardner; Miguel Habeych; Donald Crammond; Jeffrey Balzer; Lois Burkhart; Michael Horowitz
Journal:  Neurosurg Rev       Date:  2013-06-10       Impact factor: 3.042

3.  Residual hemifacial spasm after microvascular decompression: prognostic factors with emphasis on preoperative psychological state.

Authors:  Yichao Jin; Changyi Zhao; Shanshan Su; Xiaohua Zhang; Yongming Qiu; Jiyao Jiang
Journal:  Neurosurg Rev       Date:  2015-04-15       Impact factor: 3.042

4.  Internal carotid artery aneurysms, cranial nerve dysfunction and headache: the role of deformation and pulsation.

Authors:  M Rodríguez-Catarino; L Frisén; G Wikholm; J Elfverson; L Quiding; P Svendsen
Journal:  Neuroradiology       Date:  2003-03-01       Impact factor: 2.804

5.  A significant correlation between delayed cure after microvascular decompression and positive response to preoperative anticonvulsant therapy in patients with hemifacial spasm.

Authors:  Shunsuke Terasaka; Katsuyuki Asaoka; Shigeru Yamaguchi; Hiroyuki Kobayashi; Hiroaki Motegi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2016-05-28       Impact factor: 3.042

6.  Does the location of a vascular loop in the cerebellopontine angle explain pulsatile and non-pulsatile tinnitus?

Authors:  V Nowé; D De Ridder; P H Van de Heyning; X L Wang; J Gielen; J Van Goethem; O Ozsarlak; A M De Schepper; P M Parizel
Journal:  Eur Radiol       Date:  2004-10-21       Impact factor: 5.315

7.  Microvascular decompression for hemifacial spasm associated with vertebrobasilar artery.

Authors:  Joo Pyung Kim; Bong Jin Park; Seok Keun Choi; Bong Arm Rhee; Young Jin Lim
Journal:  J Korean Neurosurg Soc       Date:  2008-09-30

8.  Hemifacial spasm associated with type 1 Chiari malformation: a retrospective study of 13 cases.

Authors:  Ning Li; Wei-Guo Zhao; Chun-Hua Pu; Wen-Lei Yang
Journal:  Neurosurg Rev       Date:  2016-07-15       Impact factor: 3.042

Review 9.  Hemifacial spasm: conservative and surgical treatment options.

Authors:  Christian Rosenstengel; Marc Matthes; Jörg Baldauf; Steffen Fleck; Henry Schroeder
Journal:  Dtsch Arztebl Int       Date:  2012-10-12       Impact factor: 5.594

10.  Abnormal brain white matter in patients with hemifacial spasm: a diffusion tensor imaging study.

Authors:  Chenguang Guo; Hui Xu; Xuan Niu; Samuel Krimmel; Jixin Liu; Lin Gao; Ming Zhang; Yuan Wang
Journal:  Neuroradiology       Date:  2019-12-02       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.